Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
SMG Stock Summary
Top 10 Correlated ETFs
In the News
Ancillary Marijuana Stocks to Watch Before Q4 2023
As October 2023 approaches, the cannabis industry is still thriving, and legalization campaigns are picking more steam in many regions of the globe. This expanding industry has provided a favorable climate for ancillary companies that specialize in the necessary tools and services to aid in the growth and manufacturing of cannabis. Top marijuana stocks in the cannabis industry's support industries should be closely monitored by investors hoping to profit from the expanding cannabis sector.
3 Really Good Marijuana Stocks For Your Trading Portfolio
Marijuana stock investors have much to look forward to as the sector continues to evolve. In recent cannabis industry news, there has been another push to establish a few different bills. For starters, more states are looking to pass bills to legalize cannabis. Ultimately creating new cannibal markets and more possible investment opportunities. Not just that there is the revamp of the SAFE Banking Act that may officially become law at end of the September.
7 Cannabis Stocks to Buy BEFORE the Marijuana Rescheduling Boom
There's a reason people are looking for cannabis stocks to buy now. It is increasingly likely that marijuana will be rescheduled from a Schedule I controlled substance to a Schedule III controlled substance.
New York State opens up cannabis license process
The New York State Cannabis Control Board on Tuesday voted to open up the application process starting next month for businesses seeking to sell, grow, process and distribute marijuana for adult use. Companies with an existing presence in the state's medical program include Curaleaf Holdings CURLF, -10.69%, RIV Capital Inc. RIV, , a unit of Scotts Miracle-Gro Co. SMG, -0.19% that owns Etain dispensaries; Acreage Holdings Inc. ACRHF, -20.41%, Green Thumb Industries GTBIF, -8.60% and PharmaCann.
Top Ancillary Cannabis Stocks for September 2023
September 2023 presents an intriguing potential for investors in the ever-changing cannabis industry and top marijuana stocks environment. As legalization progresses, ancillary cannabis stocks, such as equipment providers that fuel cultivation, take center stage. This essay looks at the primary competitors to keep an eye on, technical analysis, and prudent risk management techniques.
Here are 19 stocks Jim Cramer is watching, including Chipotle, LULU and Airbnb
Here are some of the tickers on my radar for Tuesday, Sept. 5, taken directly from my reporter's notebook.
Eleventh-Hour Climbers: 7 Stocks Gearing Up for a Late Summer Surge
While some publicly traded enterprises left no doubt as to their trajectory, a few others are just now benefiting from a late summer stock surge. Better late than never, though.
Scotts (SMG) Up 0.5% Since Last Earnings Report: Can It Continue?
Scotts (SMG) reported earnings 30 days ago. What's next for the stock?
Growing Your Portfolio: Ancillary Cannabis Stocks to Watch in Q4 2023
In the ever-changing cannabis market scene, Q4 2023 offers appealing potential for investors. As legalization advances, ancillary cannabis stocks, including equipment providers that power cultivation, take center stage. This article examines the main competitors to monitor, technical analysis, and wise risk management measures.
The Top 3 Cannabis Stocks by Market Cap: Buy, Sell or Hold?
Cannabis growers, and the companies underwriting them, are well beyond the high times marking early state legalization. As state after state began approving medical and recreational cannabis, weed stocks skyrocketed on the prospect of investing in a new national commodity.
SMG Financial details
SMG Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-09-30
|Revenue per share||47.39||56.86||74.18||88.42||70.7|
|Net income per share||1.13||8.3||6.96||9.2||-7.88|
|Operating cash flow per share||6.09||4.09||10.02||4.87||-2.32|
|Free cash flow per share||4.88||3.32||8.89||2.96||-4.37|
|Cash per share||0.6||0.34||0.3||4.38||3.67|
|Book value per share||6.4||13.03||12.62||18.19||2.66|
|Tangible book value per share||-18.52||-9.42||-9.34||-5.41||-12.37|
|Share holders equity per share||6.4||13.03||12.62||18.19||2.66|
|Interest debt per share||37.42||31.59||28.75||42.61||55.65|
|Price to sales ratio||1.66||1.79||2.06||1.66||0.6|
|EV to sales||2.41||2.31||2.43||2.07||1.34|
|Enterprise value over EBITDA||15.35||9.34||14.62||11.95||14.67|
|EV to operating cash flow||18.72||32.12||17.96||37.58||-40.75|
|EV to free cash flow||23.38||39.5||20.23||61.98||-21.68|
|Free cash flow yield||0.06||0.03||0.06||0.02||-0.1|
|Debt to equity||5.61||2.28||2.16||2.26||20.11|
|Debt to assets||0.66||0.55||0.45||0.48||0.69|
|Net debt to EBITDA||4.75||2.09||2.19||2.4||8.05|
|Sales general and administrative to revenue||0.14||0.13||0.13||0.1||0.11|
|Research and developement to revenue||0.02||0.01||0.01||0.01||0.01|
|Intangibles to total assets||0.46||0.41||0.36||0.27||0.19|
|Capex to operating cash flow||-0.2||-0.19||-0.11||-0.39||0.88|
|Capex to revenue||-0.03||-0.01||-0.02||-0.02||-0.03|
|Capex to depreciation||-0.82||-0.47||-0.66||-1.14||-1.08|
|Stock based compensation to revenue||0.02||0.01||0.01||0.01||0.01|
|Return on tangible assets||0.04||0.26||0.18||0.15||-0.13|
|Tangible asset value||-1.04B||-523M||-520.4M||-301.5M||-686.5M|
|Net current asset value||-1.81B||-1.26B||-1.46B||-1.76B||-2.17B|
|Days sales outstanding||42.55||35.67||43.92||35.83||35.23|
|Days payables outstanding||30.54||36.6||51.25||64.36||50.55|
|Days of inventory on hand||97.68||92.31||81.52||118.98||160.72|
|Capex per share||-1.21||-0.76||-1.13||-1.92||-2.05|
Quarterly Fundamentals Overview
Last date of statement is 2023-07-01 for Q3
|Revenue per share||21.41||8.89||9.49||27.3||19.91|
|Net income per share||-8.01||-3.97||-1.17||1.95||0.78|
|Operating cash flow per share||8.36||9.92||-7.78||-2.41||10.01|
|Free cash flow per share||7.76||9.66||-8.31||-2.81||9.62|
|Cash per share||0.5||3.67||0.46||0.45||0.49|
|Book value per share||7.55||2.66||1.07||2.45||2.4|
|Tangible book value per share||-8.37||-12.37||-13.89||-12.16||-12.1|
|Share holders equity per share||7.55||2.66||1.07||2.45||2.4|
|Interest debt per share||63.33||54.15||62.15||64.55||55.63|
|Price to sales ratio||3.75||4.81||5.12||2.55||3.15|
|EV to sales||6.65||10.65||11.54||4.87||5.88|
|Enterprise value over EBITDA||70.02||-25.79||-141.01||33.93||65.23|
|EV to operating cash flow||17.04||9.55||-14.08||-55.14||11.69|
|EV to free cash flow||18.35||9.8||-13.18||-47.37||12.16|
|Free cash flow yield||0.1||0.23||-0.17||-0.04||0.15|
|Debt to equity||8.32||20.11||57.25||25.99||22.84|
|Debt to assets||0.7||0.69||0.75||0.72||0.69|
|Net debt to EBITDA||30.61||-14.15||-78.44||16.14||30.28|
|Sales general and administrative to revenue||0.07||0.16||0.18||0.07||0.06|
|Research and developement to revenue||0.01||0.02||0.02||0.01||0.01|
|Intangibles to total assets||0.18||0.19||0.18||0.16||0.18|
|Capex to operating cash flow||-0.07||-0.03||0.07||0.16||-0.04|
|Capex to revenue||-0.03||-0.03||-0.06||-0.01||-0.02|
|Capex to depreciation||-1.22||-0.55||-1.17||-0.99||-0.97|
|Stock based compensation to revenue||0||0.01||0.04||0.02||-0.01|
|Return on tangible assets||-0.11||-0.06||-0.02||0.03||0.01|
|Tangible asset value||-463.7M||-686.5M||-770.8M||-682.3M||-679.9M|
|Net current asset value||-1.99B||-2.17B||-2.18B||-2.01B||-2.07B|
|Days sales outstanding||72.27||69.07||83.8||85.67||93.31|
|Days payables outstanding||27.58||67.39||76.61||33.42||36.06|
|Days of inventory on hand||133.42||214.24||318.71||90.71||87.25|
|Capex per share||-0.6||-0.26||-0.53||-0.4||-0.39|
SMG Frequently Asked Questions
What is The Scotts Miracle-Gro Company stock symbol ?
The Scotts Miracle-Gro Company is a US stock , located in Marysville of Oh and trading under the symbol SMG
Is The Scotts Miracle-Gro Company buy or a sell ?
7 stock analysts have 7 predictions with a medium analyst target price of $88.86. The lowest prediction is $70 and the highest is $115
What is SMG stock prediction ?
With a median analyst target price of $76, 2 stock analysts have made 2 forecasts in last 90 days. $72 is the lowest and $80 is the greatest projection.
What is The Scotts Miracle-Gro Company stock quote today ?
The Scotts Miracle-Gro Company stock price is $51.89 today.
Is The Scotts Miracle-Gro Company stock public?
Yes, The Scotts Miracle-Gro Company is a publicly traded company.